MANTOVANI, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 9.966
AS - Asia 5.182
EU - Europa 2.138
SA - Sud America 971
Continente sconosciuto - Info sul continente non disponibili 348
AF - Africa 278
OC - Oceania 11
Totale 18.894
Nazione #
US - Stati Uniti d'America 9.724
SG - Singapore 2.994
CN - Cina 1.034
BR - Brasile 784
IT - Italia 661
VN - Vietnam 513
FI - Finlandia 317
IE - Irlanda 232
NG - Nigeria 196
DE - Germania 174
HK - Hong Kong 174
FR - Francia 157
GB - Regno Unito 146
CA - Canada 124
IN - India 104
SE - Svezia 91
NL - Olanda 80
RU - Federazione Russa 70
BD - Bangladesh 67
AR - Argentina 61
MX - Messico 46
IQ - Iraq 43
BE - Belgio 38
EC - Ecuador 33
ES - Italia 32
TR - Turchia 32
PL - Polonia 31
ZA - Sudafrica 27
CL - Cile 25
ID - Indonesia 23
IL - Israele 23
JP - Giappone 19
CO - Colombia 18
JM - Giamaica 16
PH - Filippine 15
PK - Pakistan 15
VE - Venezuela 15
UA - Ucraina 14
CH - Svizzera 12
LT - Lituania 12
NP - Nepal 12
JO - Giordania 11
MY - Malesia 11
HN - Honduras 10
HR - Croazia 10
PE - Perù 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
DO - Repubblica Dominicana 9
SA - Arabia Saudita 9
TN - Tunisia 9
UY - Uruguay 9
AU - Australia 8
BO - Bolivia 8
DZ - Algeria 8
KG - Kirghizistan 8
AZ - Azerbaigian 7
ET - Etiopia 7
MA - Marocco 7
PT - Portogallo 7
PY - Paraguay 7
AT - Austria 6
EG - Egitto 6
HU - Ungheria 6
PA - Panama 6
BG - Bulgaria 5
GR - Grecia 5
GT - Guatemala 5
KE - Kenya 5
LB - Libano 5
OM - Oman 5
TH - Thailandia 5
EU - Europa 4
NI - Nicaragua 4
SV - El Salvador 4
AL - Albania 3
AM - Armenia 3
BW - Botswana 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EE - Estonia 3
KR - Corea 3
KW - Kuwait 3
LY - Libia 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BM - Bermuda 2
BY - Bielorussia 2
IR - Iran 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
PS - Palestinian Territory 2
Totale 18.519
Città #
Singapore 1.426
Chandler 1.035
Wilmington 861
Ashburn 613
San Jose 612
Shanghai 497
The Dalles 461
Dallas 390
Helsinki 309
Ann Arbor 291
San Mateo 272
Council Bluffs 259
Beijing 251
New York 246
Milan 231
Dublin 230
Boardman 211
Benin City 193
Princeton 191
Lawrence 169
Santa Clara 164
Hong Kong 159
Los Angeles 159
Ho Chi Minh City 157
Leawood 149
Hanoi 137
Paris 106
Woodbridge 80
Fairfield 75
Phoenix 75
São Paulo 75
Rome 73
Amsterdam 61
London 53
Buffalo 47
Abbiategrasso 42
Orem 41
Seattle 39
Brussels 37
Chicago 37
Munich 34
Norwalk 33
Toronto 33
Houston 32
Atlanta 31
Rio de Janeiro 31
Brooklyn 29
Belo Horizonte 27
Naples 27
Da Nang 26
Miami 25
Pune 25
Falkenstein 24
Warsaw 24
San Diego 23
Figino 22
Haiphong 22
Brasília 21
Charlotte 20
Denver 19
San Francisco 18
Tokyo 18
Andover 17
Cleveland 17
Mexico City 16
Boston 15
Columbus 15
Curitiba 15
Dhaka 15
Frankfurt am Main 15
Las Vegas 15
Stockholm 15
Detroit 14
Falls Church 14
Montreal 14
Baghdad 13
Johannesburg 13
Redmond 13
Hillsboro 12
Manchester 12
Moscow 12
Philadelphia 12
Quito 12
Kocaeli 11
Milwaukee 11
Newark 11
Pisa 11
The Bronx 11
Biên Hòa 10
Cincinnati 10
Louisville 10
Porto Alegre 10
Richmond 10
Winnipeg 10
Amman 9
Bari 9
Chennai 9
Guayaquil 9
Kingston 9
Oakland 9
Totale 11.543
Nome #
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection? 216
Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppression 192
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade 145
Lack of IL-1R8 in neurons causes hyperactivation of IL-1 receptor pathway and induces MECP2-dependent synaptic defects. 143
Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors 142
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers 138
Anti-human migration stimulating factor (msf) and uses thereof 138
A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019 137
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 137
A cytokine/PTX3 prognostic index as a predictor of mortality in sepsis 134
Occurrence and significance of tumor - Associated neutrophils in patients with colorectal cancer 133
Tumor-associated macrophages and response to 5-flourouracil adjuvant therapy in stage III colorectal cancer 128
Mapping the human genetic architecture of COVID-19 128
ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy 125
Evolution of the pentraxin family: the new entry PTX4. 124
Pentraxins in the activation and regulation of innate immunity 123
Characterization of MEC 14.7, a new monoclonal antibody recognizing mouse CD34: a useful reage for identifying and characterizing blood vessels and hematopoietic precursors. 123
IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity 123
Anti-tumor activity of cytokines against opportunistic vascular tumors in mice. 121
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer 121
The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma 117
Control of Complement Activation by the Long Pentraxin PTX3: Implications in Age-Related Macular Degeneration 117
Implication of the oligomeric state of the N-terminal PTX3 domain in cumulus matrix assembly 116
Fluid phase recognition molecules in neutrophil-dependent immune responses 116
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 115
Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation 113
Presence of twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors 113
Tumor associated macrophages and neutrophils in cancer 112
Chemokines as Regulators of Neutrophils: Focus on Tumors, Therapeutic Targeting, and Immunotherapy 112
The Long Pentraxin PTX3 Controls Klebsiella Pneumoniae Severe Infection 112
Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers 110
ACKR2 IN HEMATOPOIETIC PRECURSORS AS A CHECKPOINT OF NEUTROPHIL RELEASE AND ANTIMETASTATIC ACTIVITY 110
3D Cocultures of Osteoblasts and Staphylococcus aureus on Biomimetic Bone Scaffolds as a Tool to Investigate the Host-Pathogen Interface in Osteomyelitis 110
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis 109
Regulation of leukocyte recruitment by the long pentraxin PTX3. 108
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. 108
SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy 108
Adverse Events to Comirnaty Vaccine Are Linked to Sex, Age and BMI: Should We Consider Reducing the Dose for Females? 108
PTX3 as a paradigm for the interaction of pentraxins with the Complement system 107
IL-1 and IL-1 regulatory pathways in cancer progression and therapy 107
Combined low densities of FoxP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression 105
AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients 105
Tumor associated macrophages and neutrophils in tumor progression. 105
A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. 104
Interplay between Myeloid Cells and Humoral Innate Immunity 103
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity 102
Neutrophil diversity and plasticity in tumour progression and therapy 102
Functional cooperation between complement factor H and the long pentraxin PTX3 in the immune response to Aspergillus fumigatus 102
Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study' 101
Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. 101
The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling 101
An integrated view of humoral innate immunity: pentraxins as a paradigm. 101
Circulating pentraxin 3 in severe COVID-19 or other pulmonary sepsis 101
Morphology of tumour-associated macrophages dictates the prognosis of patients with colorectal liver metastases 100
Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer 100
Malignant mesothelioma-associated inflammatory microenvironment promotes tumor progression via GPNMB 100
Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course 99
Purification and characterization of the motogenic properties of Migration Stimulating Factor, a genetically truncated onco-fetal isoform of human fibronectin 1 99
Complementary Roles of Short and Long Pentraxins in the Complement-Mediated Immune Response to Aspergillus fumigatus Infections 99
The long Pentraxin PTX3 serves as an early predictive biomarker of co-infections in COVID-19 98
Chemokines and chemokine receptors in the regulation of dendritic cell trafficking 98
Damping Excessive Inflammation and Tissue Damage in Mycobacterium tuberculosis Infection by Toll IL-1 Receptor 8/Single Ig IL-1-Related Receptor, a Negative Regulator of IL-1/TLR Signaling 98
The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling. 97
Macrophage diversity and polarization in atherosclerosis: a question of balance. 97
CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis : a longitudinal study 97
Innate immunity, inflammation and tumour progression: double-edged swords 97
The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease 96
Pentraxin 3 regulates synaptic function by inducing AMPA receptor clustering via ECM remodeling and β1-integrin 96
Regulation of the Chemokine System at the Level of Chemokine Receptor Expression and Signaling Activity 96
One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19 95
Chorionic gonadotropin up-regulates long pentraxin 3 expression in myeloid cells. 94
Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. 94
Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. 93
Novel pathways for negative regulation of inflammatory cytokines centered on receptor expression. 93
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation 93
PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. 92
Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation 91
Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm. 91
Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy 90
Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells. 90
Inflammatory chemokine clearance mediated by the decoy receptor d6 regulates myeloid cells accumulation in tumor-bearing mice 90
SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis. 90
Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation. 89
Nonredundant role of CCRL2 in lung dendritic cell trafficking. 89
Molecular pathways and targets in cancer-related inflammation. 88
Cigarette smoke induces PTX3 expression in pulmonary veins of mice in an IL-1 dependent manner. 87
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals 85
Pentraxins in innate immunity: lessons from PTX3. 85
Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity. 85
Toll-like receptor signaling and SIGIRR in renal fibrosis upon unilateral ureteral obstruction. 85
Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. 85
The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. 85
Cytokine regulation of endothelial cells 84
Dissecting neutrophil complexity in cancer 84
Neutrophils mediate protection against colitis and carcinogenesis by controlling bacterial invasion and IL-22 production by γδ T cells 83
Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. 83
Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6 83
Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. 83
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. 82
PTX3, A HUMORAL PATTERN RECOGNITION MOLECULE, IN INNATE IMMUNITY, TISSUE REPAIR, AND CANCER 82
Totale 10.622
Categoria #
all - tutte 118.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.453


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022922 0 0 0 167 21 20 44 116 146 116 194 98
2022/20232.777 382 124 249 334 272 217 4 220 509 215 206 45
2023/20241.772 163 146 284 104 68 234 159 108 21 61 159 265
2024/20252.597 69 32 27 55 35 329 194 245 322 648 306 335
2025/20266.496 939 439 409 586 255 256 1.812 399 373 420 271 337
2026/20272.546 597 565 1.100 284 0 0 0 0 0 0 0 0
Totale 18.894